Genovis_Q2 2012 EN

About Us

Genovis’ business concept is to develop, produce and market innovative technologies that facilitate and enable development of new treatment methods and diagnostics for customers in the medical device and pharmaceutical industries. The Group consists of Genovis AB and the the wholly owned subsidiary Genovis Inc. (USA). Genovis develops and sells unique enzymes (protein engineering portfolio) in innovative product formats that facilitate development and quality control of and biological drugs. Genovis shares are listed on NASDAQ OMX First North